本页面由Tiger Trade Technology Pte. Ltd.提供服务

Theravance Biopharma Inc.

16.78
+0.14000.84%
盘后17.230.4527+2.70%18:29 EDT
成交量:52.68万
成交额:873.70万
市值:8.64亿
市盈率:8.15
高:16.80
开:16.58
低:16.36
收:16.64
52周最高:21.03
52周最低:8.33
股本:5,149.29万
流通股本:2,184.42万
量比:1.48
换手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):2.06
每股收益(LYR):2.06
净资产收益率:44.85%
总资产收益率:-0.54%
市净率:2.91
市盈率(LYR):8.15

数据加载中...

2020/07/06

重要事件披露

8-K - Current report
2020/06/25

重要事件披露

8-K - Current report
2020/06/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report
2020/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

重要事件披露

8-K - Current report
2020/04/09

重要事件披露

Current report, items 8.01 and 9.01
2020/03/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/03

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

重要事件披露

Current report, items 1.01, 2.02, 8.01, and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals